Jubilant Pharmova slipped 2.14% to Rs 581.00 after the company announced the completion of USFDA audit of Solid dosage manufacturing facility at Roorkee with 4 observations.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
